Hudson Bay Capital Management LP Nektar Therapeutics Transaction History

Hudson Bay Capital Management LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $243,675 - $414,225	-22,500 Reduced 24.32%	70,000 $946,000
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $228,725 - $329,700	-17,500 Reduced 15.91%	92,500 $1.66 Million
Q2 2021 Aug 16, 2021	BUY	$16.52 - $20.4 $578,200 - $714,000	35,000 Added 46.67%	110,000 $1.89 Million
Q1 2021 May 14, 2021	SELL	$16.56 - $25.46 $82,800 - $127,300	-5,000 Reduced 6.25%	75,000 $1.5 Million
Q4 2020 Feb 12, 2021	SELL	$15.77 - $19.03 $709,650 - $856,350	-45,000 Reduced 36.0%	80,000 $1.36 Million
Q3 2020 Nov 12, 2020	BUY	$16.59 - $24.79 $110,870 - $165,671	6,683 Added 5.65%	125,000 $2.07 Million
Q2 2020 Aug 12, 2020	SELL	$16.86 - $23.44 $196,975 - $273,849	-11,683 Reduced 8.99%	118,317 $2.74 Million
Q4 2019 Feb 12, 2020	BUY	$15.87 - $23.12 $1.27 Million - $1.85 Million	80,000 Added 160.0%	130,000 $2.81 Million
Q3 2019 Nov 13, 2019	SELL	$16.91 - $36.27 $1.52 Million - $3.26 Million	-90,000 Reduced 64.29%	50,000 $911,000
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $310,000 - $363,000	-10,000 Reduced 6.67%	140,000 $4.98 Million
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $4.74 Million - $6.95 Million	150,000 New	150,000 $5.04 Million
Q3 2018 Nov 14, 2018	SELL	$46.46 - $68.49 $696,900 - $1.03 Million	-15,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $693,750 - $1.57 Million	15,000 New	15,000 $732,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.